Glaukos (GKOS) Capital Expenditures (2014 - 2026)
Glaukos' (GKOS) quarterly Capital Expenditures came in at $4.0 million in Q1 2026, up 104.28% year-on-year from $1.9 million in Q1 2025, and up 316.1% on a QoQ basis from -$1.8 million in Q4 2025.
Glaukos (GKOS) Capital Expenditures (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Capital Expenditures data on file, last reported at $4.0 million in Q1 2026.
- On a quarterly basis, Capital Expenditures rose 104.28% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $4.9 million, a 174.96% increase from a year earlier, with the FY2025 full-year figure at $2.9 million, up 40.72% from the prior year.
- Capital Expenditures for Q1 2026 stood at $4.0 million, up from -$1.8 million in the prior quarter.
- Over the last five years, Capital Expenditures for GKOS reached as high as $18.7 million in Q3 2022 and fell as low as -$21.7 million in Q4 2022.
- Historically, Capital Expenditures has averaged $624411.8 across 5 years, with a median of $1.2 million in 2025.
- On a YoY basis, Capital Expenditures climbed as much as 3214.88% in 2024 and fell as far as 358.57% in 2024.
- Year by year, Capital Expenditures stood at -$21.7 million in 2022, then jumped by 91.4% to -$1.9 million in 2023, then sank by 31.05% to -$2.4 million in 2024, then advanced by 25.16% to -$1.8 million in 2025, then jumped by 316.1% to $4.0 million in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $4.0 million in Q1 2026, -$1.8 million in Q4 2025, and $1.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.96 Mn |
| Mar 31, 2026 | 3.96 Mn |
| Dec 31, 2025 | -1.83 Mn |
| Dec 31, 2025 | -1.83 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 1.94 Mn |
| Mar 31, 2025 | 1.94 Mn |
| Dec 31, 2024 | -2.45 Mn |
| Dec 31, 2024 | -2.45 Mn |
| Sep 30, 2024 | 4.01 Mn |
| Sep 30, 2024 | 4.01 Mn |
| Jun 30, 2024 | -1.70 Mn |
| Jun 30, 2024 | -1.70 Mn |
| Mar 31, 2024 | 2.22 Mn |
| Mar 31, 2024 | 2.22 Mn |
| Dec 31, 2023 | -1.87 Mn |
| Dec 31, 2023 | -1.87 Mn |